111 results
Page 2 of 6
6-K
EX-99.1
aurcm
17 Oct 22
Mereo BioPharma Receives FDA Fast Track Designation for Alvelestat for Treatment of
7:16am
6-K
EX-99.1
gf5c7594redyp2 9xq2e
12 Sep 22
Data support further evaluation of PVR, CD226, and TIGIT as potential biomarkers of enrichment for etigilimab plus anti-PD1 therapy
8:17am
6-K
EX-99.1
9plk7b
31 Aug 22
Letter Reiterates Mereo’s Updated Strategic Plan to Maximize Value for All Shareholders and Corrects Rubric’s Assumptions
7:57am
6-K
EX-99.1
6akfzgxdxmh61
22 Aug 22
Notifies Rubric of Certain Deficiencies in its Notice Purporting to Call a General Meeting of Shareholders
4:06pm
6-K
EX-99.1
6ggyz
2 Jun 22
Mereo Also Updates Capital Allocation and Portfolio Prioritization Plan
9:07am
6-K
EX-99.1
xx1vmin2
26 May 22
Current report (foreign)
5:11pm
6-K
EX-3.1
hjxi127gwin9gklpm0n
17 May 22
Current report (foreign)
8:26am
6-K
f6i42oc8dcs o2akj
9 May 22
Current report (foreign)
8:06am
6-K
EX-99.1
hbhd1f96kvuohdj5lpo
9 May 22
Current report (foreign)
8:06am
6-K
EX-99.1
dpf1042b
31 Mar 22
Mereo BioPharma Reports Full Year 2021 Financial Results and Recent Highlights
4:18pm
6-K
pcnya9h13fzu
14 Mar 22
Current report (foreign)
10:05am
6-K
EX-99.1
dom7g3nn
14 Mar 22
Current report (foreign)
10:05am